Matches in Ubergraph for { <http://purl.obolibrary.org/obo/NCIT_C37557> ?p ?o ?g. }
Showing items 1 to 51 of
51
with 100 items per page.
- NCIT_C37557 IAO_0000115 "A regimen consisting of bevacizumab and erlotinib that may be used in the treatment of epidermal growth factor receptor (EGFR)-positive kidney cancer and non-small cell lung cancer (NSCLC)." @default.
- NCIT_C37557 NCIT_NHC0 "C37557" @default.
- NCIT_C37557 NCIT_P106 "Therapeutic or Preventive Procedure" @default.
- NCIT_C37557 NCIT_P108 "Bevacizumab/Erlotinib Regimen" @default.
- NCIT_C37557 NCIT_P207 "C1327881" @default.
- NCIT_C37557 NCIT_P366 "Bevacizumab_Erlotinib" @default.
- NCIT_C37557 NCIT_R123 NCIT_C129821 @default.
- NCIT_C37557 NCIT_R123 NCIT_C129822 @default.
- NCIT_C37557 NCIT_R123 NCIT_C129824 @default.
- NCIT_C37557 NCIT_R123 NCIT_C129825 @default.
- NCIT_C37557 NCIT_R123 NCIT_C1404 @default.
- NCIT_C37557 NCIT_R123 NCIT_C163758 @default.
- NCIT_C37557 NCIT_R123 NCIT_C163952 @default.
- NCIT_C37557 NCIT_R123 NCIT_C1742 @default.
- NCIT_C37557 NCIT_R123 NCIT_C1908 @default.
- NCIT_C37557 NCIT_R123 NCIT_C1909 @default.
- NCIT_C37557 NCIT_R123 NCIT_C1967 @default.
- NCIT_C37557 NCIT_R123 NCIT_C198860 @default.
- NCIT_C37557 NCIT_R123 NCIT_C2039 @default.
- NCIT_C37557 NCIT_R123 NCIT_C20401 @default.
- NCIT_C37557 NCIT_R123 NCIT_C2167 @default.
- NCIT_C37557 NCIT_R123 NCIT_C2189 @default.
- NCIT_C37557 NCIT_R123 NCIT_C2496 @default.
- NCIT_C37557 NCIT_R123 NCIT_C2693 @default.
- NCIT_C37557 NCIT_R123 NCIT_C274 @default.
- NCIT_C37557 NCIT_R123 NCIT_C307 @default.
- NCIT_C37557 NCIT_R123 NCIT_C308 @default.
- NCIT_C37557 NCIT_R123 NCIT_C471 @default.
- NCIT_C37557 normalizedInformationContent "100" @default.
- NCIT_C37557 referenceCount "1" @default.
- NCIT_C37557 hasExactSynonym "Avastin-Tarceva" @default.
- NCIT_C37557 hasExactSynonym "Avastin/Tarceva" @default.
- NCIT_C37557 hasExactSynonym "Bevacizumab-Erlotinib Regimen" @default.
- NCIT_C37557 hasExactSynonym "Bevacizumab-Erlotinib" @default.
- NCIT_C37557 hasExactSynonym "Bevacizumab/Erlotinib Regimen" @default.
- NCIT_C37557 hasExactSynonym "Erlotinib-Bevacizumab" @default.
- NCIT_C37557 hasExactSynonym "Erlotinib/Bevacizumab Regimen" @default.
- NCIT_C37557 hasExactSynonym "Erlotinib/Bevacizumab" @default.
- NCIT_C37557 hasExactSynonym "Tarceva/Avastin" @default.
- NCIT_C37557 type Class @default.
- NCIT_C37557 isDefinedBy ncit.owl @default.
- NCIT_C37557 label "Bevacizumab/Erlotinib Regimen" @default.
- NCIT_C37557 subClassOf B15509303027d50ad8f2148b9f1c3d412 @default.
- NCIT_C37557 subClassOf B83c6b0cc6a202cc461ffd3806f6cf641 @default.
- NCIT_C37557 subClassOf B8648e387c8883c8f2501b7c4be4a4e12 @default.
- NCIT_C37557 subClassOf Bb98c3d62c828a3e3285874aa031d87a1 @default.
- NCIT_C37557 subClassOf NCIT_C12218 @default.
- NCIT_C37557 subClassOf NCIT_C37557 @default.
- NCIT_C37557 subClassOf NCIT_C62634 @default.
- NCIT_C37557 subClassOf NCIT_C63360 @default.
- NCIT_C37557 subClassOf NCIT_C67290 @default.